Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Johnson

Showing results (211-220 of 221) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trialsDaphne W Bell, Thomas J Lynch, Sara M Haserlat, et al.
Plant Physiology|September 7, 2014
Broad 4-hydroxyphenylpyruvate dioxygenase inhibitor herbicide tolerance in soybean with an optimized enzyme and expression cassetteDaniel L Siehl, Yumin Tao, Henrik Albert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Bryan J Schneider, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2021
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Andrew G Robinson, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 18, 2010
Thymic malignanciesDavid S Ettinger, Wallace Akerley, Gerold Bepler, et al.
Nature Medicine|November 20, 2025
Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Nature Medicine|September 1, 2014
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2010
Non-small cell lung cancerDavid S Ettinger, Wallace Akerley, Gerold Bepler, et al.
Pageof 23

Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trialsDaphne W Bell, Thomas J Lynch, Sara M Haserlat, et al.
Plant Physiology|September 7, 2014
Broad 4-hydroxyphenylpyruvate dioxygenase inhibitor herbicide tolerance in soybean with an optimized enzyme and expression cassetteDaniel L Siehl, Yumin Tao, Henrik Albert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Bryan J Schneider, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2021
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Andrew G Robinson, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 18, 2010
Thymic malignanciesDavid S Ettinger, Wallace Akerley, Gerold Bepler, et al.
Nature Medicine|November 20, 2025
Editorial Expression of Concern: Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Nature Medicine|September 1, 2014
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancerChristine M Lovly, Nerina T McDonald, Heidi Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2010
Non-small cell lung cancerDavid S Ettinger, Wallace Akerley, Gerold Bepler, et al.
Pageof 23